Noel Laudi

3.6k total citations
6 papers, 56 citations indexed

About

Noel Laudi is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Noel Laudi has authored 6 papers receiving a total of 56 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 2 papers in Immunology. Recurrent topics in Noel Laudi's work include Viral-associated cancers and disorders (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Noel Laudi is often cited by papers focused on Viral-associated cancers and disorders (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Noel Laudi collaborates with scholars based in United States. Noel Laudi's co-authors include Philip B. McGlave, Jeffrey S. Miller, Linda J. Burns, Mukta Arora, Juliet N. Barker, Daniel J. Weisdorf, Paul J. Orchard, James E. Coad, Tyson Rogers and Norma K.C. Ramsay and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Gastrointestinal Surgery.

In The Last Decade

Noel Laudi

6 papers receiving 55 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noel Laudi United States	4	43	36	14	13	10	6	56
R. Andrew Harkins United States	4	27 0.6×	45 1.3×	20 1.4×	9 0.7×	11 1.1×	7	69
Astrid Pavlovsky Argentina	5	22 0.5×	32 0.9×	11 0.8×	9 0.7×	4 0.4×	21	62
Jason T. Romancik United States	5	44 1.0×	33 0.9×	13 0.9×	12 0.9×	17 1.7×	17	64
Nurgul Kilavuz United States	4	49 1.1×	30 0.8×	7 0.5×	18 1.4×	9 0.9×	7	59
Joe Sneath Thompson United Kingdom	2	19 0.4×	36 1.0×	12 0.9×	14 1.1×	4 0.4×	3	48
Anna Alperovich United States	4	19 0.4×	27 0.8×	16 1.1×	7 0.5×	3 0.3×	10	42
Lanie E. Happ United States	4	19 0.4×	17 0.5×	9 0.6×	12 0.9×	9 0.9×	9	41
Will Donnellan United States	4	37 0.9×	46 1.3×	14 1.0×	7 0.5×	3 0.3×	6	73
Jurik Mutter Germany	1	23 0.5×	46 1.3×	12 0.9×	6 0.5×	10 1.0×	2	53
Katya Ahr United States	3	20 0.5×	29 0.8×	16 1.1×	6 0.5×	7 0.7×	4	45

Countries citing papers authored by Noel Laudi

Since Specialization

Citations

This map shows the geographic impact of Noel Laudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noel Laudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noel Laudi more than expected).

Fields of papers citing papers by Noel Laudi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noel Laudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noel Laudi. The network helps show where Noel Laudi may publish in the future.

Co-authorship network of co-authors of Noel Laudi

This figure shows the co-authorship network connecting the top 25 collaborators of Noel Laudi. A scholar is included among the top collaborators of Noel Laudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noel Laudi. Noel Laudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Gadgeel, Shirish M., Jieling Miao, Jonathan W. Riess, et al.. (2023). Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042). Clinical Cancer Research. 29(18). 3641–3649. 9 indexed citations

2.

Tarhini, Ahmad A., Sandra J. Lee, Xiaoxue Li, et al.. (2018). E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma. Clinical Cancer Research. 25(2). 524–532. 6 indexed citations

3.

Tarhini, Ahmad A., Sandra J. Lee, Uma N. M. Rao, et al.. (2017). A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611).. Journal of Clinical Oncology. 35(15_suppl). 9542–9542. 1 indexed citations

4.

Laudi, Noel, Mukta Arora, Linda J. Burns, et al.. (2006). Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma. American Journal of Hematology. 81(7). 519–524. 19 indexed citations

5.

Banton, Kaysie L., Jonathan D’Cunha, Noel Laudi, et al.. (2005). Postoperative Severe Microangiopathic Hemolytic Anemia Associated With a Giant Hepatic Cavernous Hemangioma. Journal of Gastrointestinal Surgery. 9(5). 679–685. 1 indexed citations

6.

Laudi, Noel, Mukta Arora, Linda J. Burns, et al.. (2005). Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation. 11(2). 129–135. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact